BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19447939)

  • 1. Clinical correlates of self-reported physical health status in systemic sclerosis.
    Hudson M; Steele R; Lu Y; Thombs BD; Panopalis P; Baron M;
    J Rheumatol; 2009 Jun; 36(6):1226-9. PubMed ID: 19447939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II.
    Hudson M; Thombs BD; Steele R; Watterson R; Taillefer S; Baron M;
    Arthritis Rheum; 2008 Feb; 59(2):279-84. PubMed ID: 18240196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Work disability in systemic sclerosis.
    Hudson M; Steele R; Lu Y; Thombs BD; ; Baron M
    J Rheumatol; 2009 Nov; 36(11):2481-6. PubMed ID: 19797513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
    Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
    Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of dyspnoea to function and quality of life in systemic sclerosis.
    Baron M; Sutton E; Hudson M; Thombs B; Markland J; Pope J; Robinson D; Jones N; Docherty P; Abu-Hakima M; LeClercq S; Smith D; Mathieu JP
    Ann Rheum Dis; 2008 May; 67(5):644-50. PubMed ID: 17728334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases.
    Johnson SR; Glaman DD; Schentag CT; Lee P
    J Rheumatol; 2006 Jun; 33(6):1117-22. PubMed ID: 16622903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions.
    Hudson M; Thombs BD; Steele R; Panopalis P; Newton E; Baron M;
    J Rheumatol; 2009 Apr; 36(4):768-72. PubMed ID: 19228662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis.
    Malcarne VL; Hansdottir I; McKinney A; Upchurch R; Greenbergs HL; Henstorf GH; Furst DE; Clements PJ; Weisman MH
    J Rheumatol; 2007 Feb; 34(2):359-67. PubMed ID: 17304659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers.
    Del Rosso A; Boldrini M; D'Agostino D; Placidi GP; Scarpato A; Pignone A; Generini S; Konttinen Y; Zoppi M; Vlak T; Placidi G; Matucci-Cerinic M
    Arthritis Rheum; 2004 Jun; 51(3):475-81. PubMed ID: 15188336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
    Khanna D; Furst DE; Clements PJ; Park GS; Hays RD; Yoon J; Korn JH; Merkel PA; Rothfield N; Wigley FM; Moreland LW; Silver R; Steen VD; Weisman M; Mayes MD; Collier DH; Medsger TA; Seibold JR; ;
    J Rheumatol; 2005 May; 32(5):832-40. PubMed ID: 15868618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients.
    Thombs BD; Hudson M; Bassel M; Taillefer SS; Baron M;
    Arthritis Rheum; 2009 Jul; 61(7):966-73. PubMed ID: 19565539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database.
    Baron M; Hudson M; Steele R;
    J Rheumatol; 2009 Dec; 36(12):2737-43. PubMed ID: 19833750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pain in health related quality of life of patients with systemic sclerosis.
    Georges C; Chassany O; Toledano C; Mouthon L; Tiev K; Meyer O; Ilie D; Rambeloarisoa J; Marjanovic Z; Cabane J; Sereni D; Pouchot J; Farge D
    Rheumatology (Oxford); 2006 Oct; 45(10):1298-302. PubMed ID: 16754629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.
    Salaffi F; Cimmino MA; Malavolta N; Carotti M; Di Matteo L; Scendoni P; Grassi W;
    J Rheumatol; 2007 Jul; 34(7):1551-60. PubMed ID: 17516618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of health-related quality of life in patients treated with hemodialysis in Serbia: influence of comorbidity, age, and income.
    Stojanovic M; Stefanovic V
    Artif Organs; 2007 Jan; 31(1):53-60. PubMed ID: 17209961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
    Khanna D; Yan X; Tashkin DP; Furst DE; Elashoff R; Roth MD; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M; Clements PJ;
    Arthritis Rheum; 2007 May; 56(5):1676-84. PubMed ID: 17469162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma.
    Sekhon S; Pope J; ; Baron M
    J Rheumatol; 2010 Mar; 37(3):591-8. PubMed ID: 20080913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in systemic sclerosis: psychometric properties of the World Health Organization Disability Assessment Schedule II.
    Hudson M; Steele R; Taillefer S; Baron M;
    Arthritis Rheum; 2008 Feb; 59(2):270-8. PubMed ID: 18240187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
    Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Seibold JR
    Arthritis Rheum; 2001 Mar; 44(3):653-61. PubMed ID: 11263780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.